7th Norwegian Life Science Investor Partnering Day
When
16. Apr09:00 AM - 08:00 AMWhere
Oslo Science Park, Meeting room: Toppsenteret, 1:1 meetings at H2B and Toppsenteret
Organizer
The Life Science Cluster, Norway Health Tech, Oslo Cancer Cluster
When
Where
Oslo Science Park, Meeting room: Toppsenteret, 1:1 meetings at H2B and Toppsenteret
Organizer
“Investing in Future Health & Life Sciences Technologies – Small-Market Innovators Going Global” is the theme for the 7th Norwegian Life Science Investor Partnering Day.
Life science is entering a new phase. Capital is shifting, investor expectations are evolving, and companies must demonstrate not only strong science, but scalable and globally relevant business models. From strategic pharma partnerships to venture capital recalibrating its playbook, the investment landscape is being reset.
For small-market innovators, this raises critical questions: How do you attract international capital? What defines an investable company in today’s market? And how can Nordic strengths in sustainability, digitalisation, advanced therapeutics and AI translate into global impact?
Norway and the Nordics are uniquely positioned to contribute to the next generation of solutions for human and planetary health. But realising this potential requires alignment between founders, investors, and strategic partners.
Hear Nordic and international investors and thought leaders reflect around the Norwegian and Nordic investment landscape, and meet investors and life science companies for 1:1 partnering.
How do investors look at the challenges and opportunities that come with them?
Learn how Norwegian life science is well positioned to contribute to the next generation of solutions to human and planetary health, and how the Nordics is well positioned for a sustainable and digital life science industry.
Last year’s conference brought ca. 140 participants and nearly 100 1:1 meetings between investors and companies.
Moderator of the day: Anne Ulvestad, Founding Executive Director, Innosiamo
08:00 – 09:00
Breakfast & Registration
09:00 – 09:15
Opening Remarks – The Investment Reset, Capital Shifts Across Life Science
Delphine Costa, CEO, The Life Science Cluster & Shokouh Makvandi-Nejad, Head of Investments and Strategic Projects, The Life Science Cluster
09:15 – 09:40
Keynote: The Life Science Investor Playbook for the Next Decade
9:40 – 10:05
Panel Discussion: The Future of Life Science Capital, Where Investment Is Moving and Why It Matters
10:05 – 10:30
Strategic Capital in Life Sciences: How Pharma Invests, Partners, and Helps Scale Innovation Globally
Sergio Capancioni, Director Search & Evaluation, International, AbbVie
10:30 – 11:00
Coffee Break & Meet-the-Speakers Q&A
11:00 – 11:50
Reverse Pitch Session: Meet the Investors
Karina Wessel, Impact Manager, Bluefront Equity
11:50 – 12:50
Networking Lunch & 1:1 Partnering
12:50 – 13:15
Nordic Scale-Up Spotlight (a success story): Building Global Impact from a Small Market
13:15 – 13:40
Parallel sessions
Session A: Building Investable Bio-Innovation: What Investors Look for in Sustainable and Blue-Green Life Sciences (location: H2B)
Karina Wessel, Impact Manager, Bluefront Equity
Session B: Funding Advanced Therapeutics: From Breakthrough Science to Scalable, Affordable Healthcare (location: Toppsenteret)
13:40 – 14.00: Coffee Break & Meet-the-Speakers Q&A
14:00 – 14:30
New funding opportunities for Nordic life science
Anne Maria Eikeset & Andrew W. Lo
14:30 – 14.55
Panel Discussion: AI, Data, and Automation in Life Sciences, Hype vs Investable Reality (Investors point of view)
Marko Kuisma, Partner, Innovestor
14:55 – 15:15
Closing Reflections: What Founders Should Prioritise in the Next Funding Cycle
15:15 – 16:00
Networking & Follow-Up Meetings
16.00
Partnering end
16.00 – 18.00
Rooftop reception with finger food and refreshments
—
On-site 1:1 partnering meetings will be scheduled through the HelloPartnering platform. Partnering will be opened on ca 21 of March. Each meeting slot is 30 minutes and can be pre-booked before the conference date.
